TO PROMOTE RESEARCH FOR THE BENEFIT OF THE PUBLIC BY THE PROMOTION AND FUNDING OF RESEARCH AND CLINICAL TRIALS OF LOW DOSE NALTREXONE (LDN) AS TREATMENT FOR MULTIPLE SCLEROSIS AND THE PUBLICATION OF THE RESULTS OF SUCH RESEARCH.
Whilst working to raise funds for trials, we have helped over 3,000 people with Multiple Sclerosis to obtain LDN from a General Practitioner or Neurologist, either through the National Health Service or by private prescription.
registerd charity number 1106636